
Financials · Financial Exchanges & Data
$256.21
-3.71%
Vol: 844K
Tuesday, June 16, 2026
CME Group launched options on Eris SOFR Swap futures on June 16, 2026, broadening its interest-rate product lineup as it pushes a wave of new offerings. The exchange operator is also rolling out four new E-mini equity index futures contracts, including products tied to the Morningstar U.S. Total Market Index and Russell 3000 Index, and plans 24/7 trading for a new smaller-sized crude oil contract and its 1-Ounce Gold futures, pending regulatory review. Q1 2026 revenue rose 14%, though the company slightly missed earnings expectations. Rothschild & Co Redburn upgraded CME to Buy from Neutral with a $323 price target, while Piper Sandler reiterated Overweight at $329. Shares trade near $266. The main risk is rising competition and regulatory scrutiny around new product launches, particularly the proposed oil futures.
CME Group announced a wave of product expansions: options on Eris SOFR Swap futures launch June 16, 2026, and the exchange will add four new E-mini equity index futures contracts starting June 29 covering more than 90% of the US investable market cap. It also launched Bitcoin Volatility Index futures and struck a licensing agreement with Morningstar, deepening its push into crypto and broad-market exposure. The stock trades around $263.68 with a ~4.4% dividend yield and a $1.30 quarterly dividend (ex-date June 9). Q1 revenue rose 14%, though the company slightly missed earnings expectations. The bear case: CME faces regulatory scrutiny over its proposed 24/7 trading plans and rising competition in derivatives, and analysts hold a mixed outlook despite the steady product cadence.
No material news in the last 48 hours.
No material news in the last 48 hours.
On May 14, 2026, CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, 2026 pending regulatory review. The financially-settled contracts will track the largest and most actively traded cryptocurrencies including bitcoin, ether, SOL, XRP, ADA, LINK, and stellar. On May 12, 2026, CME partnered with Silicon Data to create a futures market for AI computing power, helping traders, financial firms, AI builders and cloud providers manage volatility. The 2026 Annual Meeting on May 14 saw shareholders re-elect directors led by Terrence Duffy and ratify Ernst & Young as auditor. Sports event contracts on men's international soccer and women's professional basketball launched on CME Globex on May 7, 2026. April 2026 ADV reached 25.9 million contracts. Average analyst rating is Buy with a $307.42 target.
CME Group published a May 18, 2026 markets update flagging that risk assets are sliding as the G7 addresses geopolitical risks and trade, providing a real-time read on hedging demand into its futures complex. The company continues to roll out new contracts, including Bitcoin Volatility futures, Avalanche (AVAX) and Sui (SUI) crypto futures, a planned June 8 Nasdaq CME Crypto Index futures launch, and a first-of-its-kind compute-capacity futures exchange with Silicon Data based on GPU benchmarks. CME also declared a second-quarter dividend of $1.30 per share and reported April 2026 ADV of 25.9 million contracts. The bear case is that insiders have sold $19M in stock recently and the consensus price target of $307.42 implies only ~7% upside from $305.12. Brand Finance again named CME the most valuable exchange brand for the 11th consecutive year.
CME Group announced two major new product initiatives in May 2026: on May 12, the partnership with Silicon Data to launch a first-of-its-kind compute futures market enabling traders, AI builders, and cloud providers to hedge multi-trillion-dollar compute pricing risk, and on May 14, plans to launch Nasdaq CME Crypto Index futures on June 8 covering BTC, ETH, SOL, XRP, ADA, LINK and lumens. The company also launched new AVAX and SUI futures on May 6 and announced Bitcoin Volatility futures launching in June. Shares surged 4.0% to $297.13 on May 13 after rising 0.47% to $282.58 on May 11. CME shareholders re-elected all 14 directors and ratified EY as auditor at the May 14 annual meeting. Bear case: crypto and compute-futures revenue contribution remains small initially; trading volume growth is sensitive to macro volatility, and rate-cut cycles could reduce demand for interest-rate hedging products.
CME Group announced on May 14, 2026 the planned launch of Nasdaq CME Crypto Index futures on June 8, pending regulatory review, covering BTC, ETH, SOL, XRP, ADA, LINK, and XLM. On May 12, CME and Silicon Data unveiled plans for a first-of-its-kind compute futures market for AI/cloud capacity hedging. CME also released its preliminary annual meeting results, with all 14 directors elected and Ernst & Young ratified as auditor. These product launches expand CME into high-growth crypto and compute hedging markets, reinforcing its position as the leading derivatives venue.
On May 12, 2026, CME Group announced a partnership with index provider Silicon Data to launch the first regulated futures market for computing power, based on Silicon Data's daily GPU rental rate benchmarks, pending regulatory review. The news pushed shares up 4.0% on May 13 to $297.13, building on a separate May 5 announcement that CME plans to launch Bitcoin Volatility futures on June 1, settling to its CME CF Bitcoin Volatility Index. Q1 2026 revenue grew 14.5% to $1.88 billion and diluted EPS climbed to $3.18 from $2.62 a year earlier. The exchange also rolled out Avalanche and Sui crypto futures on May 6 and declared a quarterly dividend on May 7. The bear case is execution risk on novel products and dependence on continued macro volatility for trading volumes.
On May 12, CME Group announced a partnership with Silicon Data to launch compute futures contracts, pending regulatory review, allowing traders, AI builders and cloud providers to hedge GPU price volatility based on Silicon Data daily GPU benchmark indices. This expands CME product set into the AI infrastructure stack. Separately, CME announced Bitcoin Volatility futures launching June 1, plus new Avalanche and Sui crypto futures with first block trades May 6 and 24/7 trading starting May 29. The Board declared a $1.30 Q2 dividend payable June 25. Q1 results were strong with revenue up 14.5% to $1.88B and diluted EPS of $3.18 vs $2.62 prior year.
CME Group announced plans to launch first-of-their-kind Bitcoin Volatility futures on June 1, pending regulatory review, settling to the CME CF Bitcoin Volatility Index (BVX), a 30-day forward-looking measure of implied volatility. The contracts allow investors to isolate volatility risk from price direction. CME also debuted Avalanche (AVAX) and Sui (SUI) futures with first block trades reported May 6, executed between FalconX and G-20 Group, and the full crypto futures suite will trade 24/7 starting May 29. CME declared a Q2 dividend of $1.30/share, payable June 25 to holders of record June 9. Effective May 7, event contracts on men's international soccer and women's professional basketball were listed on CME Globex. The 2026 annual shareholder meeting is scheduled for May 14. Analyst consensus on CME stands at Buy across 12 analysts as of May 11. Risk: regulatory delays could push back the volatility futures launch.
CME Group declared a Q2 dividend of $1.30 per share payable June 25 to holders of record June 9. On May 6, CME executed first block trades of new Avalanche (AVAX) and Sui (SUI) futures with FalconX and G-20 Group providing initial liquidity. CME's full crypto futures suite will move to 24/7 trading starting May 29, 2026, aligning with global spot markets. Earlier in May, the company also announced Bitcoin Volatility futures launching June 1 pending regulatory review. The 2026 Annual Meeting is scheduled May 14. The crypto-trading expansion broadens revenue lines but also exposes CME to higher operational and regulatory complexity.
CME Group expanded cryptocurrency offerings with Avalanche (AVAX) and Sui (SUI) futures starting May 6, 2026, with 24/7 trading launching May 29. Bitcoin Volatility futures announced for June 1 launch pending regulatory review—first-of-their-kind contracts allowing investors to isolate volatility risks from price direction. CME launched U.S. dollar RepoFunds Rate (RFR USD) for repo market benchmarking. Q1 2026 showed record trading volumes and revenues with slight EPS/revenue misses. Second-quarter dividend declared at $1.30 per share. Consensus Buy rating from 12 analysts.
CME Group reported record Q1 2026 revenue of $1,880.1M and record adjusted operating income/EPS despite slight EPS miss. Energy complex hit new single-day volume record of 8.3M contracts on March 6. April averaged 25.9M daily contracts across all asset classes. Treasury futures open interest reached record 36.3M contracts, and DTCC/CME received regulatory approval for expanded Treasury cross-margining. Cryptocurrency futures/options will trade 24/7 starting May 29, pending regulatory review. All asset classes showing strong engagement and growth. Analysts rate at Buy with target of $307.42.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| SPGIS+P | $433.24 | +2.16% | +1.6% | 19.1x | 1.08 | $125.5B |
| CMECME | $256.21 | -3.71% | -12.8% | 20.6x | 0.24 | $96.1B |
| MCOMOODY | $466.53 | +2.75% | +2.4% | 24.4x | 1.34 | $79.3B |
| ICEINTERCONTINENTAL | $139.76 | -0.25% | -10.2% | 15.9x | 0.92 | $79.2B |
| NDAQNASDAQ | $88.81 | -2.45% | -1.7% | 20.5x | 0.97 | $51.5B |
| COINCOINBASE | $167.82 | -1.06% | -10.5% | 34.3x | 3.32 | $44.7B |
Price below 200d MA — bearish structure.